RTA2, a novel gene involved in azole resistance in Candida albicans

Biochemical and Biophysical Research Communications

Volumn 373, Issue 4, 2008, Pages 631-636

  Jia, Xin Ming ^a   Ma, Zhi Ping ^b   Jia, Yu ^a   Gao, Ping Hui ^a   Zhang, Jun Dong ^a   Wang, Yan ^a   Xu, Yong Gang ^a   Wang, Lin ^a   Cao, Ying Ying ^a   Cao, Yong Bing ^a   Zhang, Li Xin ^c   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b School of Medicine   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Azole resistance; Candida albicans; Gene disruption; RTA2

Indexed keywords

ANTIFUNGAL AGENT; BREFELDIN A; CERULENIN; ECONAZOLE; FLUCONAZOLE; FLUPHENAZINE; ITRACONAZOLE; KETOCONAZOLE; NYSTATIN; PYRROLE DERIVATIVE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CAMDR1 GENE; CANDIDA ALBICANS; CDR1 GENE; CDR2 GENE; FUNGAL GENE; FUNGAL STRAIN; GENE CONTROL; GENE DELETION; GENE DISRUPTION; GENE OVEREXPRESSION; IPF14030 GENE; MICROARRAY ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RTA2 GENE;

ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; FUNGAL PROTEINS; GENES, FUNGAL; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

CANDIDA ALBICANS;

EID: 48949115092     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.06.093     Document Type: Article

References (33)

1. Baddley J.W., and Moser S.A. Emerging fungal resistance. Clin. Lab. Med. 2004 (2003) 721-735
2. Perea S., and Patterson T.F. Antifungal resistance in pathogenic fungi. Clin. Infect. Dis. 35 (2002) 1073-1080
3. Pfaller M.A., and Diekema D.J. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. 42 (2004) 4419-4431
4. Sahm D.F., Benninger M.S., Evangelista A.T., Yee Y.C., Thornsberry C., and Brown N.P. Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005). Otolaryngol. Head Neck Surg. 136 (2007) 385-389
5. T. Tetsuya, D. Katsura, T. Yoshitaka, N. Takayuki, M. Tomoshige, H.A.N. Yuki, A.N.O. Hiromi, Y. Hiroko, K. Kunimitsu, T. Izuo, Treatment outcome of patients with multidrug-resistant pulmonary tuberculosis during pregnancy, Journal Code Z0657A 81 (2006) 413-418.
6. Siquier B., Sanchez-Alvarez J., Garcia-Mendez E., Sabria M., Santos J., Pallares R., Twynholm M., and Dal-Re R. On behalf of the 620 Clinical Study, Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae. J. Antimicrob. Chemother. 57 (2006) 536-545
7. Prasad R., and Kapoor K. Multidrug resistance in yeast Candida. Int. Rev. Cytol. 242 (2004) 215-248
8. Prasad R., De Wergifosse P., Goffeau A., and Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27 (1995) 320-329
9. Sanglard D., Kuchler K., Ischer F., Pagani J.L., Monod M., and Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39 (1995) 2378-2386
10. White T.C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41 (1997) 1482-1487
11. Prasad R., and Kapoor K. Multidrug resistance in yeast Candida. Int. Rev. Cytol. 242 (2005) 215-248
12. Calabrese D., Bille J., and Sanglard D. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146 Pt 11 (2000) 2743-2754
13. Sanglard D., Ischer F., Koymans L., and Bille J. Amino acid substitutions in the cytochrome P-450 lanosterol 14alpha-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents Chemother. 42 (1998) 241-253
14. Barker K.S., Crisp S., Wiederhold N., Lewis R.E., Bareither B., Eckstein J., Barbuch R., Bard M., and Rogers P.D. Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J. Antimicrob. Chemother. 54 (2004) 376-385
15. Chau A.S., Mendrick C.A., Sabatelli F.J., Loebenberg D., and McNicholas P.M. Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles. Antimicrob. Agents Chemother. 48 (2004) 2124-2131
16. White T.C., Holleman S., Dy F., Mirels L.F., and Stevens D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob. Agents Chemother. 46 (2002) 1704-1713
17. Cowen L.E., Nantel A., Whiteway M.S., Thomas D.Y., Tessier D.C., Kohn L.M., and Anderson J.B. Population genomics of drug resistance in Candida albicans. Proc. Natl. Acad. Sci. USA 99 (2002) 9284-9289
18. Rogers P.D., and Barker K.S. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 47 (2003) 1220-1227
19. Xu Z., Zhang L.X., Zhang J.D., Cao Y.B., Yu Y.Y., Wang D.J., Ying K., Chen W.S., and Jiang Y.Y. cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients. Int. J. Med. Microbiol. (2006)
20. Hooshdaran M.Z., Barker K.S., Hilliard G.M., Kusch H., Morschhauser J., and Rogers P.D. Proteomic analysis of azole resistance in Candida albicans clinical isolates. Antimicrob. Agents Chemother. 48 (2004) 2733-2735
21. Kusch H., Biswas K., Schwanfelder S., Engelmann S., Rogers P.D., Hecker M., and Morschhauser J. A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Mol. Genet. Genomics 271 (2004) 554-565
22. Calvet H.M., Yeaman M.R., and Filler S.G. Reversible fluconazole resistance in Candida albicans: a potential in vitro model. Antimicrob. Agents Chemother. 41 (1997) 535-539
23. Ghannoum M.A., Ibrahim A.S., Fu Y., Shafiq M.C., Edwards Jr. J.E., and Criddle R.S. Susceptibility testing of Cryptococcus neoformans: a microdilution technique. J. Clin. Microbiol. 30 (1992) 2881-2886
24. Wang Y., Cao Y.Y., Jia X.M., Cao Y.B., Gao P.H., Fu X.P., Ying K., Chen W.S., and Jiang Y.Y. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic. Biol. Med. 40 (2006) 1201-1209
25. Noble S.M., and Johnson A.D. Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryot. Cell 4 (2005) 298-309
26. Fonzi W.A., and Irwin M.Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134 (1993) 717-728
27. Sanglard D., Ischer F., Monod M., and Bille J. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40 (1996) 2300-2305
28. Care R.S., Trevethick J., Binley K.M., and Sudbery P.E. The MET3 promoter: a new tool for Candida albicans molecular genetics. Mol Microbiol 34 (1999) 792-798
29. Edlind T., Smith L., Henry K., Katiyar S., and Nickels J. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling. Mol. Microbiol. 46 (2002) 257-268
30. Henry K.W., Cruz M.C., Katiyar S.K., and Edlind T.D. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents. Antimicrob. Agents Chemother. 43 (1999) 1968-1974
31. Karababa M., Valentino E., Pardini G., Coste A.T., Bille J., and Sanglard D. CRZ1 a target of the calcineurin pathway in Candida albicans. Mol. Microbiol. 59 (2006) 1429-1451
32. Hirokawa T., Boon-Chieng S., and Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 14 (1998) 378-379
33. Kihara A., and Igarashi Y. Identification and characterization of a Saccharomyces cerevisiae gene, RSB1, involved in sphingoid long-chain base release. J. Biol. Chem. 277 (2002) 30048-30054